Founded in 1987, Pooyesh Darou Pharmaceuticals today is one of the most well established biotechnology companies through the Middle East. With 6 recombinant biopharmaceutical products helping patients in the country, Pooyesh Darou Pharmaceuticals became regional leader in the effort to develop and apply the most advanced capabilities in biotechnology to address a range of unmet medical needs.
Pooyesh Darou Pharmaceuticals has acquired technology exclusively from the ICGEB (United Nations’ International Center for Genetic Engineering and Biotechnology, Trieste-ITALY) to manufacture recombinant-DNA-based therapeutic proteins, the endogenous hormones and leukotriene that control essential body functions. The company is the first in Iran to use these genetically modified bacteria and cells to produce basic endogenous proteins.
Our biotechnological plant for production of therapeutic drugs is in complete compliance with cGMP rules and regulations. Pooyesh Darou Pharmaceuticals manufacturing spaces’ elements such as building materials, space design, facilities and flows, have considered all the environmental regulations and meet all quality criteria for manufacturing biological products.
Our collaboration with department of biotechnology at Tehran University of Medical Sciences (TUMS) and the International Center for Genetic Engineering and Biotechnology (ICGEB) at Trieste-ITALY has created a unique opportunity for research and development of many therapeutic drugs.
Pooyesh Darou Pharmaceuticals’ QC laboratories are equipped with all necessary reagents and equipment to perform complete QC tests for biological products. The latest versions of pharmacopeias such as USP and BP are being used for the QC analysis of our all row materials and products.
We enjoy our collaboration with the best experts in this field such as ICGEB in Trieste-ITALY, Primm labs (GLP certified laboratory) in Milan-ITALY and the National Institute for Biological Standards and Control (NIBSC) in London-UK